Problem 10 - Campbell Biology

Question

SCIENTIFIC INQUIRY Fifty years ago, pregnant women who were prescribed thalidomide for morning sickness gave birth to children with birth defects. Thalidomide is a mixture of two enantiomers; one reduces morning sickness, but the other causes severe birth defects. Today, the FDA has approved this drug for non-pregnant individuals with Hansen's disease (leprosy) or newly diagnosed multiple myeloma, a blood and bone marrow cancer. The beneficial enantiomer can be synthesized and given to patients, but over time, both the beneficial and the harmful enantiomer can be detected in the body. Propose a possible explanation for the presence of the harmful enantiomer.

Step-by-Step Solution

Answer

Racemization in the body converts the beneficial enantiomer to the harmful one.

Step 1: Understand the Concept of Enantiomers

Enantiomers are molecules that are mirror images of each other but cannot be superimposed. These enantiomers can have drastically different effects in biological systems.

Step 2: Identify the Problem

The problem is that despite administering only the beneficial enantiomer, the harmful enantiomer is still detected in the body.

Step 3: Recognize the Role of Chiral Inversions

A chiral center in a molecule can undergo inversion, which means the beneficial enantiomer could potentially be converted into the harmful enantiomer within the body. This process is called racemization.

Step 4: Refer to Biological Environment

The human body has enzymes and other chemical entities that might facilitate the conversion between enantiomers. These enzymatic reactions could lead to the presence of both enantiomers over time.

Step 5: Conclude the Explanation

The presence of the harmful enantiomer could be due to racemization, where the beneficial enantiomer is converted into the harmful one within the body's biological environment.

Key Concepts

Chiral Inversions

Enantiomers are like your left and right hands—they look alike but are mirror images and cannot be perfectly aligned. This uniqueness of enantiomers makes them act differently in the body. Chiral inversion is a process where one enantiomer converts into its mirror image. In pharmacology, this can be particularly troublesome. For example, thalidomide exists as two enantiomers: one helps reduce morning sickness, while the other leads to birth defects.

When only the beneficial enantiomer of thalidomide is administered, chiral inversion may still lead to the harmful enantiomer showing up in the body. This can happen spontaneously or due to specific conditions in the body. Understanding chiral inversions helps scientists develop better medications by considering both forms of enantiomers.

Racemization

Racemization is the process where a single enantiomer converts into a racemic mixture. In simple terms, a racemic mixture contains equal amounts of both enantiomers. This is significant in drug development because even if a drug is administered as a single, beneficial enantiomer, racemization can convert it into a mix of both beneficial and harmful enantiomers over time.

Thalidomide is a classic example where racemization poses risks. Even when the beneficial form is prescribed, the body’s conditions can cause it to convert into the harmful form. This unpredictability necessitates careful monitoring and informed pharmaceutical practices to minimize risks associated with racemization.

Keeping track of racemization helps pharmacists and doctors ensure safer and more effective medication dosing.

Enzymatic Reactions

Enzymatic reactions in the body involve enzymes that facilitate chemical reactions, including those that can convert one enantiomer into another. In the case of thalidomide, enzymes might trigger the conversion of the beneficial enantiomer into the harmful one. Enzymes work as biological catalysts that change the rate of reactions without being consumed themselves.

These reactions are crucial because the body's enzymes may not distinguish between different enantiomers. As a result, both forms of thalidomide can be found in the body after administration.

Researchers study enzymatic pathways to predict these conversions and develop mechanisms to inhibit unwanted reactions. By understanding these enzymatic reactions, medical professionals can better manage how drugs behave inside the body, reducing the risk of harmful side effects.